CS
CRGX

Credit Suisse’s CARGO Therapeutics CRGX Stock Holding History

Credit Suisse’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$340K Buy
+15,221
New +$362K ﹤0.01% 2788

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Credit Suisse's CRGX Position: Q1 2024 in Review

Credit Suisse opened a new position in CARGO Therapeutics (CRGX) in Q1 2024: 15,221 shares worth $340K. The stake represents ﹤0.01% of the portfolio and ranks #2788 among its holdings.

65 funds tracked by Wall St. Rank hold CRGX as of Q1 2024.

  • Credit Suisse held 15,221 shares of CARGO Therapeutics worth $340K as of Q1 2024.
  • CARGO Therapeutics was a new Credit Suisse position in Q1 2024.
  • CARGO Therapeutics made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2788 holding.
  • 65 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.